Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic cancer vaccine: building the future from lessons of the past
Thi Tran, Charlotte Blanc, Clémence Granier, et al.
Seminars in Immunopathology (2018) Vol. 41, Iss. 1, pp. 69-85
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
Colby S. Shemesh, Joy Hsu, Iraj Hosseini, et al.
Molecular Therapy (2020) Vol. 29, Iss. 2, pp. 555-570
Open Access | Times Cited: 204
Vaccine-like nanomedicine for cancer immunotherapy
Yunfei Yi, Mian Yu, Wen Li, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 760-778
Closed Access | Times Cited: 87
Selecting Target Antigens for Cancer Vaccine Development
Luigi Buonaguro, Maria Tagliamonte
Vaccines (2020) Vol. 8, Iss. 4, pp. 615-615
Open Access | Times Cited: 104
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo, Sara M. Mangsbo, Divya Nagarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 95
Immunotherapy in hepatocellular carcinoma
Luigi Buonaguro, Angela Mauriello, Beatrice Cavalluzzo, et al.
Annals of Hepatology (2019) Vol. 18, Iss. 2, pp. 291-297
Open Access | Times Cited: 77
Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives
Xiaotong Chen, Ju Yang, Lifeng Wang, et al.
Theranostics (2020) Vol. 10, Iss. 13, pp. 6011-6023
Open Access | Times Cited: 77
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
Yaqi Zhao, Zheming Liu, Lan Li, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 67
Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity
Yudi Xu, Sheng Ma, Jiayu Zhao, et al.
Biomaterials (2022) Vol. 284, pp. 121489-121489
Closed Access | Times Cited: 60
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
Yue Zhao, Kongyuan Wei, Hao Chi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Tumor microenvironment antigens
Mads Hald Andersen
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 253-264
Open Access | Times Cited: 47
Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination
Vahideh Mohammadzadeh, Niloufar Rahiman, Horacio Cabral, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 278-296
Closed Access | Times Cited: 26
Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy
Yingxuan Zhang, Zheyan Fang, Ruizhen Li, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1314-1314
Open Access | Times Cited: 74
Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
Concetta Ragone, Carmen Manolio, Beatrice Cavalluzzo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 5, pp. e002694-e002694
Open Access | Times Cited: 47
Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy
Shaobo Ruan, Zachary Greenberg, Xiaoshu Pan, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 41
Neoantigen‐based cancer vaccination using chimeric RNA‐loaded dendritic cell‐derived extracellular vesicles
Xiao Xiong, Xiurong Ke, Lu Wang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 37
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer
Laura Seclì, Guido Leoni, Valentino Ruzza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16591-16591
Open Access | Times Cited: 17
A self‐assembled, genetically engineered, irradiated tumor cell debris vaccine
Yajie Sun, Yan Hu, Yuanyuan Geng, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 6
BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications
Jooeun Bae, Neha N. Parayath, Wenxue Ma, et al.
Leukemia (2019) Vol. 34, Iss. 1, pp. 210-223
Open Access | Times Cited: 47
Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions
Hang Wu, Xianglei Fu, Yujia Zhai, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 13
Closed Access | Times Cited: 40
Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Shiyi Zuo, Jiaxuan Song, Jingxuan Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7471-7487
Open Access | Times Cited: 39
Advanced nano-based strategies for mRNA tumor vaccine
Yangqi Qu, Jingjing Xu, Tong Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 170-189
Open Access | Times Cited: 14
Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 5
Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches
Maria Tagliamonte, Angela Mauriello, Beatrice Cavalluzzo, et al.
Cancer Letters (2019) Vol. 473, pp. 25-32
Open Access | Times Cited: 39
Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies
Ligong Lu, Jun Jiang, Meixiao Zhan, et al.
Hepatology (2020) Vol. 73, Iss. 2, pp. 821-832
Closed Access | Times Cited: 36
Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy
Y Zeng, Qing Gu, Dan Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 12, pp. 2455-2473
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top